Thyquidity patents expiration

THYQUIDITY's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9050307 VISTAPHARM Method for the preparation of a levothyroxine solution
Aug, 2031

(7 years from now)

Thyquidity is owned by Vistapharm.

Thyquidity contains Levothyroxine Sodium.

Thyquidity has a total of 1 drug patent out of which 0 drug patents have expired.

Thyquidity was authorised for market use on 30 November, 2020.

Thyquidity is available in solution;oral dosage forms.

The generics of Thyquidity are possible to be released after 06 August, 2031.

Drugs and Companies using LEVOTHYROXINE SODIUM ingredient

Market Authorisation Date: 30 November, 2020

Treatment: NA


How can I launch a generic of THYQUIDITY before it's drug patent expiration?
More Information on Dosage

THYQUIDITY family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic